— Know what they know.
Not Investment Advice

000411.SZ SHZ

Zhejiang Int'l Group Co.,Ltd.
1W: +0.4% 1M: +2.0% 3M: +11.1% YTD: -19.1% 1Y: -11.2% 3Y: -13.3% 5Y: +0.3%
¥10.02 ($1.49)
+0.04 (+0.40%)
 
SHZ · Healthcare · Drug Manufacturers - General · Tech Score Neutral · Power 60 · ¥5.7B mcap · 582M float · 1.37% daily turnover

Income Trends

Revenue
$33.4B +4.1% ▲
5Y CAGR: +6.3%
Gross Profit
$2.3B +5.0% ▲
5Y CAGR: +7.0%
Operating Income
$839M +1.5% ▲
5Y CAGR: +12.4%
Net Income
$526M +7.5% ▲
5Y CAGR: +9.2%
EPS (Diluted)
$0.98 -4.9% ▼
5Y CAGR: -4.4%
EBITDA
$1.2B +1.0% ▲
5Y CAGR: +10.0%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$25.0B$26.7B$30.6B$32.1B$33.4B
YoY Growth+1.7%+6.9%+14.5%+4.7%+4.1%
Cost of Revenue$23.5B$25.0B$28.6B$29.9B$31.1B
Gross Profit$1.6B$1.7B$2.0B$2.2B$2.3B
Gross Margin6.2%6.5%6.5%6.8%6.9%
R&D Expenses$2M$9M$13M$9M$12M
SG&A Expenses$613M$671M$754M$554M$553M
Operating Expenses$960M$1.1B$1.2B$1.4B$1.5B
Operating Income$468M$559M$644M$826M$839M
Operating Margin1.9%2.1%2.1%2.6%2.5%
Interest Expense$140M$160M$156M$162M$155M
Income Before Tax$466M$541M$626M$801M$803M
Tax Expense$124M$144M$164M$213M$191M
Net Income$343M$396M$463M$489M$526M
Net Margin1.4%1.5%1.5%1.5%1.6%
EPS (Diluted)$1.15$1.24$1.42$1.03$0.98
EBITDA$680M$836M$933M$1.1B$1.2B
Shares Outstanding299M320M327M474M538M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms